| Financial Year |
March 31 2023 |
| Monetary Funds |
242,239,129.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
278,984,233.34 |
| Accounts Receivable |
182,230,204.19 |
| Advances to Suppliers |
130,510,483.49 |
| Other Receivables |
61,573.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
144,024,323.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
1,019,342,525.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,043,612,883.39 |
| Investment Properties |
-- |
| Fixed Assetes |
76,136,935.75 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
17,540,921.43 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,555,851.99 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,139,846,592.56 |
| Total Assets |
2,159,189,117.58 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
335,531,882.23 |
| Accounts Payable |
61,128,349.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,115,541.35 |
| Taxes Payable |
665,442.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
25,029.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
107,154,238.35 |
| Sub-Total of Current Liabilities |
512,977,608.82 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
118,081,002.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
119,356,419.62 |
| Total Liabilities |
632,334,028.44 |
| Paid-In Capital(Or Share Stock) |
266,327,839.00 |
| Capital Surplus |
45,130,417.83 |
| Surplus Reserve |
133,163,919.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,082,232,912.81 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,526,855,089.14 |
| Owner's Equity（Stockholder's Equity） |
1,526,855,089.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,159,189,117.58 |
